General Research

 

 

Jump to:

 

 

Page 6
(2013-2016)

Halberstadt, Powell & Geyer (2013). Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology.

Halberstadt & Geyer (2013). Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology.

Halpern (2013). Psychedelic vision. BioSocieties.

Hanks & González-Maeso (2013). Animal models of serotonergic psychedelics. ACS Chemical Neuroscience.

Icaza & Mashour (2013). Altered states: psychedelics and anesthetics. Anesthesiology.

Langlitz (2013). Psychedelics: From clinic to art studio, from rainforest to church. BioSocieties.

McGeeney (2013). Cannabinoids and hallucinogens for headache. Headache.

Miech et al. (2013). The effects of the military's antidrug policies over the life course: the case of past-year hallucinogen use. Substance Use & Misuse.

Muthukumaraswamy et al. (2013). Broadband cortical desynchronization underlies the human psychedelic state. The Journal of Neuroscience.

Krebs & Johansen (2013). Psychedelics and mental health: A population study. PLoS ONE.

Krebs & Johansen (2013). Over 30 million psychedelic users in the United States. F1000Research.

Nutt, King & Nichols (2013). Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews Neuroscience.

Paulke et al. (2013). Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches. Journal of Ethnopharmacology.

Páleníček et al. (2013). Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology.

Prabhakar (2013). Exposure to potent hallucinogens in an adolescent: a case for high index of suspicion. The Primary Care Companion for CNS Disorders.

Reissig et al. (2013). Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology.

Schüll (2013). Neuropsychedelia: The revival of Hallucinogen research since the decade of the brain. BioSocieties.

Stebelska (2013). Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities. Therapeutic Drug Monitoring.

Addy (2014). On the archetypal nature of bad trips and freakouts. PsycCRITIQUES.

Baumeister et al. (2014). Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Carbonaro, Forster & Gatch (2015). The role of serotonin 2A and 2C receptors in tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine. Drug and Alcohol Dependence.

Carhart-Harris et al. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience.

Dos Santos (2014). Psychedelics, glutamate, and neuroimaging studies. Anesthesiology.

Dutta (2014). The metaphysical combat with death in the terminally ill and the psychedelic trail. Journal of Cancer Research and Therapeutics.

Dyck (2014). Review of NEUROPSYCHEDELIA : The revival of hallucinogen research since the decade of the brain. Journal of the History of the Behavioral Sciences.

Hendricks (2014). Back to the future: A return to psychedelic treatment models for addiction. Journal of Psychopharmacology.

Leth-Petersen (2014). Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability. Neurochemical Research.

Litjens et al. (2014). Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases. European Neuropsychopharmacology.

Nichols (2014). The Heffter Research Institute: Past and hopeful future. Journal of Psychoactive Drugs.

Pichini et al. (2014). Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers. Journal of Pharmaceutical and Biomedical Analysis.

Rhead (2014). Review of Psychedelic medicine: New evidence for hallucinogenic substances as treatments, Volumes 1 and 2. Journal of Psychoactive Drugs.

Sessa (2014). Developing psychotropics: From karma to pharma. PsycCRITIQUES.

Sessa (2014). Why psychiatry needs psychedelics and psychedelics need psychiatry. Journal of Psychoactive Drugs.

Tagliazucchi et al. (2014). Enhanced repertoire of brain dynamical states during the psychedelic experience. Human Brain Mapping.

Alonso et al. (2015). Serotonergic psychedelics temporarily modify information transfer in humans. International Journal of Neuropsychopharmacology.

Baggott (2015). Psychedelics and creativity: a review of the quantitative literature. PeerJ PrePrints.

Bennet & Alarcón (2015). Hunting and hallucinogens: The use psychoactive and other plants to improve the hunting ability of dogs. Journal of Ethnopharmacology.

Bolstridge (2015). Tomorrow never knows. The Lancet Psychiatry.

Bouso et al. (2015). Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. European Neuropsychopharmacology.

Burish et al. (2015). Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine. The Neurohospitalist.

Carbonaro et al. (2015). The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice. Psychopharmacology.

Elcock (2015). A Conversation with Ed Rosenfeld. Journal for the Study of Radicalism.

Elcock (2015). The fifth freedom: The politics of psychedelic patriotism. Journal for the Study of Radicalism.

Fantegrossi et al. (2015). Hallucinogen-like effects of 2-(2-(4-cyano-2,5-dimethoxyphenyl) ethylaminomethyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice. Psychopharmacology.

Gallimore (2015). Restructuring consciousness—The psychedelic state in light of integrated information theory. Frontiers in Human Neuroscience.

Garcia-Romeu, Himelstein & Kaminker (2015). Self-transcendent experience: a grounded theory study. Qualitative Research.

Garcia-Romeu et al. (2015). Psychedelic-facilitated smoking cessation: An online survey. Drug and Alcohol Dependence.

Halberstadt (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural Brain Research.

Hendricks et al. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology.

Johnstad (2015). User perceptions of mental health consequences of hallucinogen use in self-identified spiritual contexts. Nordic Studies on Alcohol and Drugs.

Johansen & Krebs (2015). Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology.

Krebs (2015). Protecting the human rights of people who use psychedelics. The Lancet Psychiatry.

Letheby (2015). The philosophy of psychedelic transformation. Journal of Consciousness Studies.

Lev-Ran et al. (2015). Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation. The American Journal on Addictions.

Majić, Schmidt & Gallinat (2015). Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology.

Nesvåg, Bramness & Ystrom (2015). The link between use of psychedelic drugs and mental health problems. Journal of Psychopharmacology.

Nour & Krzanowski (2015). Therapeutic potential of psychedelic agents. The British Journal of Psychiatry.

Noushad et al. (2015).  25 years of hallucinogen persisting perception disorder--a diagnostic challenge. British Journal of Medical Practitioners.

Pathania (2015). Therapeutic potential of psychedelic agents. The British Journal of Psychiatry.

Rivera-García et al. (2015). Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems. Psychopharmacology.

Ruane (2015). Harm Reduction or Psychedelic Support? Caring for Drug-Related Crises at Transformational Festivals. Dancecult: Journal of Electronic Dance Music Culture.

Rucker (2015). Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential. BMJ.

Sami et al. (2015). Psychosis, psychedelic substance misuse and head injury: A case report and 23 year follow-up. Brain Injury.

Sessa (2015). Turn on and tune in to evidence-based psychedelic research. The Lancet.

Sessa & Johnson (2015). Can psychedelic compounds play a part in drug dependence therapy? The British Journal of Psychiatry.

Sjöstrand (2015). [Curiosity without borders. Aldous Huxley tried hallucinogens to look towards another world.] Lakartidningen.

Szabo (2015). Psychedelics and immunomodulation: novel approaches and therapeutic opportunities. Frontiers in Immunology.

Tupper et al. (2015). Psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ.

Vito et al. (2015). Juvenile hallucinogen use: what do multiple theories say about it? American Journal of Criminal Justice.

Zawilska & Andrzejcak (2015). Next generation of novel psychoactive substances on the horizon—A complex problem to face. Drug and Alcohol Dependence.

Apud (2016). Pharmacology of consciousness or pharmacology of spirituality? a historical review of psychedelic clinical studies. Journal of Transpersonal Psychology.

Cameron (2016). Look again at psychedelic drugs: there is renewed interest in the therapeutic benefits of these drugs in treating chronic conditions and palliative care. Nursing Standard.

Dos Santos et al. (2016). Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging. Neuroscience and Biobehavioral Reviews.

Haden, Emerson & Tupper (2016). A public-health-based vision for the management and regulation of psychedelics. Journal of Psychoactive Drugs.

Hartogsohn (2016). Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology.

Bogenschutz & Johnson (2016). Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology & Biological Psychiatry.

Bouso et al. (2016). Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens. Human Psychopharmacology.

Brodrick & Mitchell (2016). Hallucinogen persisting perception disorder and risk of suicide. Journal of Pharmacy Practice.

Dakwar (2016). The death and rebirth of hallucinogens. Drug and Alcohol Dependence.

Davenport (2016). Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache. CMAJ.

Garcia-Romeu, Kersgaard & Addy (2016). Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology.

Goodwin (2016). An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates. Journal of Pharmacological and Toxicological Methods.

Haden, Emerson & Tupper (2016). A public-health-based vision for the management and regulation of psychedelics. Journal of Psychoactive Drugs.